Stay updated with the latest pharmaceutical-industry news, articles, and insights from trusted sources. Explore in-depth coverage and expert analysis on pharmaceutical-industry topics.
New Delhi, Apr 9 (PTI) The government has stepped up supplies of critical petrochemical feedstock to the pharmaceutical industry to ensure uninterrupted production of essential medicines, as global supply chains remain strained due to the crisis in West Asia. Prior to the West Asia conflict, the pharmaceutical industry imported a bulk of its petrochemical feedstock, mostly in Kandla, Gujarat, from where the logistics chain took them to factories. The war, however, has disrupted those imports, w ...Read More >
Indore: India's pharmaceutical sector is facing a slowdown due to the ongoing conflict between the United States, Israel, and Iran. Apart from petrol and LPG gas, the war has led to an increase in the prices of raw materials used in drug manufacturing as well, particularly those sourced from China. The cost has gone up between 40% and 100%, which is expected to disrupt supply chains. According to JP Mulchandani, President of the Basic Drug Dealers Association, Indore, the Indian pharmaceutical ...Read More >
New Delhi: The government is holding discussions with Assam Petrochemicals and Gujarat Narmada Valley Fertilizers & Chemicals Limited (GNFC) to ensure an adequate supply of methanol for the pharmaceutical industry, which has been impacted due to disruptions in global supply chains arising from the ongoing West Asia crisis. Speaking during the Inter-Ministerial Briefing on Recent Developments in West Asia on Thursday, Satyaprakash TL, Joint Secretary, Department of Pharmaceuticals, Ministry of C ...Read More >
New Delhi [India], April 9 (ANI): The government is holding discussions with Assam Petrochemicals and Gujarat Narmada Valley Fertilizers & Chemicals Limited (GNFC) to ensure an adequate supply of methanol for the pharmaceutical industry, which has been impacted due to disruptions in global supply chains arising from the ongoing West Asia crisis. Speaking during the Inter-Ministerial Briefing on Recent Developments in West Asia on Thursday, Satyaprakash TL, Joint Secretary, Department of Pharmac ...Read More >
Hyderabad, April 4 (RAHNUMA): The Government of India reaffirmed strong support for the pharmaceutical sector at a high-level Chintan Shivir organized by the Department of Commerce and Pharmexcil. The inaugural session was chaired by Rajesh Agrawal, Secretary, Department of Commerce. Senior officials including the Chairman of Pharmexcil and Joint Secretary from the Department of Pharmaceuticals addressed the gathering. The Commerce Secretary, in his address, highlighted the strong growth traje ...Read More >
Average salary increments across India Inc. are expected to remain largely stable at 9.1 per cent in 2026, marginally higher than the 9 per cent increase recorded in 2025, according to the "Deloitte India Talent Outlook 2026" report released by Deloitte on Monday. The survey, conducted between January and February 2026, gathered responses from organisations across seven sectors and 27 sub-sectors in India, primarily from chief human resources officers and senior HR leaders. The report also rec ...Read More >
Hyderabad: The Chintan Shivir on the Pharmaceutical Sector, organized by the Pharmaceutical Export Promotion Council of India (PHARMEXCIL), with the support of the Ministry of Commerce & Industry, Government of India, concluded successfully today in Hyderabad. This event marked the continuation of the series of discussions, following successful editions in Chandigarh and Ahmedabad, and served as a platform for strengthening India's pharmaceutical export agenda. The inaugural session, chaired by ...Read More >
KURNOOL: Supplies of medicines in government hospitals across Andhra Pradesh are under severe strain, raising concerns over treatment for poor patients. Availability of essential drugs at state-run hospitals has dwindled significantly over the past few weeks due to rising input costs. Officials said global tensions, including the Iran war, have pushed up crude oil prices, increasing the cost of pharmaceutical inputs and disrupting supply. Drugs meant for the fourth quarter of 2025-26, expected ...Read More >
HYDERABAD: India's pharmaceutical exports touched nearly USD 28.29 billion by February this financial year, marking a 5.6% growth compared to last year, a top official said at the Chintan Shivir-Scaling up Pharma Exports programme held in Hyderabad on Saturday. Organised by the Pharmaceutical Export Promotion Council of India (Pharmexcil) with support from the Union government, the event was chaired by commerce secretary Rajesh Agarwal, who said India's pharmaceutical industry, valued at around ...Read More >
New Delhi: Commerce secretary Rajesh Agrawal Saturday asked the pharmaceutical industry to reduce its dependence on critical imported raw materials by meeting atleast 80-90% of domestic pharmaceutical requirements through indigenous production. Addressing an event in Hyderabad, he said while India exports to around 200 countries, there remains significant scope for expansion and resilience-building through a stronger market presence. Emphasising the need to navigate an increasingly uncertain a ...Read More >
Striking a cautiously optimistic note, a senior official in the Commerce Ministry and representatives of the Pharmaceuticals Export Promotion Council of India on Saturday said FY26 pharma exports are expected to remain in the positive zone notwithstanding the West Asia war's impact on the March performance. For the 11 months upto February, the exports were nearly $28.29 billion as against the $26.79 billion in the corresponding period of previous fiscal. "We have already achieved 5.6% growth up ...Read More >
New Delhi [India], April 4 (ANI): The Indian Pharmacopoeia Commission ( IPC), which acts as the National Coordination Centre for the Pharmacovigilance Programme of India (PvPI) and provides evidence-based research to CDSCO, will be monitoring the safety of weight loss drugs. The Indian Pharmacopoeia Commission will be compiling a report of adverse events which are associated with the GLP-1 drugs. Also Read | Indian Railways Carries 1,670 MT Freight, Runs 25,000 Trains Daily in Financial Year 20 ...Read More >
New Delhi: The government is working to ensure minimal disruption to supply chains amid global uncertainties, while remaining prepared for a potential dip in exports and imports, Commerce Secretary Rajesh Agrawal said on Saturday. Addressing the press conference on the sidelines of a 'Chintan Shivir' session in Hyderabad, Agrawal told the media that the initiative aims to bring together government and industry stakeholders to identify challenges and chart a clear roadmap. The official also sta ...Read More >
New Delhi [India], April 4 (ANI): The Indian Pharmacopoeia Commission ( IPC), which acts as the National Coordination Centre for the Pharmacovigilance Programme of India (PvPI) and provides evidence-based research to CDSCO, will be monitoring the safety of weight loss drugs. The Indian Pharmacopoeia Commission will be compiling a report of adverse events which are associated with the GLP-1 drugs. According to the Official sources, the IPC has started the regular monitoring of adverse events of ...Read More >
New Delhi, Apr 4 (PTI) Commerce Secretary Rajesh Agrawal on Saturday asked the pharmaceutical industry to reduce its dependence on critical imported raw materials and diversify export supply chains to better navigate global uncertainties. Addressing an event in Hyderabad on the sector, he said while India exports to around 200 countries, there remains significant scope for expansion and resilience-building through a stronger market presence. Emphasising the need to navigate an increasingly unc ...Read More >
Bengaluru (Karnataka) [India], April 4 (ANI): The ongoing conflict in West Asia is sending ripples through the pharmaceutical industry, with raw material costs on the rise, says Jatish Sheth, Director of Srushti Pharmaceuticals. While speaking to ANI, Sheth highlighted that pharmaceuticals are vulnerable to disruptions in petrochemical supply chains, as many raw materials used in formulation are petrol-based. Also Read | WWE SmackDown Free Live Streaming Online, April 3: Get Wrestling Weekly E ...Read More >
Bengaluru (Karnataka) [India], April 4 (ANI): The ongoing conflict in West Asia is sending ripples through the pharmaceutical industry, with raw material costs on the rise, says Jatish Sheth, Director of Srushti Pharmaceuticals. While speaking to ANI, Sheth highlighted that pharmaceuticals are vulnerable to disruptions in petrochemical supply chains, as many raw materials used in formulation are petrol-based. "Pharmaceuticals are affected. Raw materials which are used for manufacturing formula ...Read More >
Chennai: The US has imposed 100 per cent duty on the import of patented pharmaceuticals and associated pharmaceutical ingredients. Generic drugs have been kept out of the duty for the time being. But, if pharma companies increasingly seek evergreening of patents, they will see fewer off-patented drugs in the pipeline. "I have determined that it is necessary and appropriate to impose a 100 percent ad valorem duty rate on the import of patented pharmaceuticals and associated pharmaceutical ingred ...Read More >
New Delhi [India], April 3 (ANI): US President Donald Trump's decision to impose a 100 per cent tariff on patented pharmaceutical imports--citing national security and supply chain risks following a Section 232 probe--is expected to have a mixed impact on India. Crucially for India, the proclamation clarifies that generic drugs--a segment in which Indian firms dominate globally--are exempt "at this time," adding that such products "shall not be subject to Section 232 tariffs." For India, the i ...Read More >
New Delhi [India], April 3 (ANI): US President Donald Trump's decision to impose a 100 per cent tariff on patented pharmaceutical imports--citing national security and supply chain risks following a Section 232 probe--is expected to have a mixed impact on India. Crucially for India, the proclamation clarifies that generic drugs--a segment in which Indian firms dominate globally--are exempt "at this time," adding that such products "shall not be subject to Section 232 tariffs." Also Read | Delh ...Read More >
Lupin announced the completion of its acquisition of VISUfarma B.V. (VISUfarma), a leading European specialty pharmaceutical company focused on ophthalmology, from GHO Capital Partners LLP (GHO). The acquisition represents a significant milestone in Lupin's strategy to expand its specialty care portfolio and strengthen its presence in Europe. The integration of VISUfarma has significantly expanded Lupin's ophthalmology portfolio to over 60 branded products spanning dry eye, glaucoma, eyelid hyg ...Read More >
New Delhi, Apr 2 (PTI) Shares of Sai Parenteral's, a diversified pharmaceutical formulation company, on Thursday ended with a premium of nearly 4 per cent against the issue price of Rs 392. The stock made its market debut at Rs 405, up 3.32 per cent from the issue price on the BSE. During the day, it rose 6.17 per cent to hit an intra-day high of Rs 416.20. Later, it ended at Rs 406.40, up 3.67 per cent on the exchange. On the NSE, shares of Sai Parenteral started trading at Rs 400, up 2.04 pe ...Read More >
Mumbai: Alkem is doubling down on its manufacturing ambitions, significantly scaling up its Ujjain project as it sharpens focus on future capacity and growth in formulations. Investment Push Accelerates The company's board has approved raising the investment cap to INR 1036 crores for its upcoming greenfield formulations manufacturing facility in Ujjain. This marks a sharp jump from the earlier approved INR 533 crores. The phased investment signals a stronger commitment to expanding domestic m ...Read More >
Qdenga vaccine against dengue (image is for representation purposes only) AI generated image ShowQuick Read Summary is AI-generated, newsroom-reviewed * Qdenga dengue vaccine expected to launch in India by 2026 after regulatory approval * Vaccine developed by Takeda Pharma, to be made in India with Biological E under Make-in-India * Qdenga requires two doses and protects against all dengue serotypes, including prior infections Did our AI summary help? Let us know. Switch To Beeps Mode ...Read More >
New Delhi [India], April 2 (ANI): Lupin Ltd. has completed the acquisition of VISUfarma B.V, a European pharmaceutical company focused on ophthalmology, the company said in an exchange filing on Thursday. Lupin said the acquisition is a "significant milestone" in its strategy to expand the speciality care portfolio and strengthen its presence in the European region. "The integration of VISUfarma has significantly expanded Lupin's ophthalmology portfolio to over 60 branded products spanning dry ...Read More >
NEW DELHI - India has abolished import tax on petrochemicals used for making plastics and pharmaceutical goods after the government invoked emergency powers and diverted local chemicals for production of cooking gas due to shortages caused by the Iran war. The import tax exemption on 40 products is valid till June 30, according to a government statement on April 2. "The government's decision to grant customs duty exemption on select petrochemical products appears aimed at easing cost pressures ...Read More >
New Delhi : Godrej Enterprises Group and Tata Capital have entered into a strategic partnership to accelerate India's intralogistics transformation by introducing structured finance lease solutions -- an emerging and differentiated model in the Indian forklift and material handling equipment market. The collaboration enables businesses to scale operations without large upfront capital expenditure and aims to finance lease assets worth ₹100 crore over the next three years. With sectors such as e ...Read More >
NEW DELHI, April 2 (Reuters) - India has abolished import tax on petrochemicals used for making plastics and pharmaceutical goods after the government invoked emergency powers and diverted local chemicals for production of cooking gas due to shortages caused by the Iran war. The import tax exemption, opens new tab on 40 products is valid till June 30, according to a government statement on Thursday. "The government's decision to grant customs duty exemption on select petrochemical products ap ...Read More >
NEW DELHI: Amid continued violations and the widespread misuse and easy availability of weight loss drugs in the market, the Centre on Wednesday warned that those who break the rules "will face licence cancellation, fines and legal action." In a detailed note on GLP 1 drugs, their use, risks and regulation, the Centre said multiple variants of weight loss drugs have recently been introduced in the Indian market, raising concerns over their on demand availability through retail pharmacies, onlin ...Read More >
Hyderabad : Granules India Limited today announced that its wholly owned subsidiary, Granules Life Sciences Private Limited (GLS), has concluded a recent US FDA inspection of its manufacturing facility at Shamirpet, Telangana, with an inspection classification of Voluntary Action Indicated (VAI). The Establishment Inspection Report (EIR) was issued following a current Good Manufacturing Practice (cGMP) and pre approval inspection (PAI) of the oral solid dosage manufacturing operations conducted ...Read More >
Stay updated with the latest None news, articles, and insights from trusted sources. Explore in-depth coverage and expert analysis on None topics.